Steven P Millard
Overview
Explore the profile of Steven P Millard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shao Y, Todd K, Shutes-David A, Millard S, Brown K, Thomas A, et al.
medRxiv
. 2023 Feb;
PMID: 36798376
The application of machine learning (ML) tools in electronic health records (EHRs) can help reduce the underdiagnosis of dementia, but models that are not designed to reflect minority population may...
2.
Lehavot K, Millard S, Thomas R, Yantsides K, Upham M, Beckman K, et al.
J Consult Clin Psychol
. 2021 Mar;
89(2):134-142.
PMID: 33705169
Objective: Scalable, efficiently delivered treatments are needed to address the needs of women Veterans with PTSD. This randomized clinical trial compared an online, coach-assisted cognitive behavioral intervention tailored for women...
3.
Hendrickson R, Millard S, Pagulayan K, Peskind E, Raskind M
Chronic Stress (Thousand Oaks)
. 2021 Feb;
5:2470547020979780.
PMID: 33623856
Background: The α-adrenoreceptor antagonist prazosin has in many but not all studies been found to be effective for PTSD associated nightmares, hyperarousal symptoms, and total symptom severity. The particular efficacy...
4.
Kim H, Leverenz J, Burdick D, Srivatsal S, Pate J, Hu S, et al.
Parkinsons Dis
. 2018 Dec;
2018:3719578.
PMID: 30515290
Background: The Washington State Parkinson Disease Registry (WPDR) was created to facilitate recruitment for Parkinson's disease (PD) research studies conducted in the Pacific Northwest. The success of registries that rely...
5.
Simpson T, Saxon A, Stappenbeck C, Malte C, Lyons R, Tell D, et al.
Am J Psychiatry
. 2018 Aug;
175(12):1216-1224.
PMID: 30153753
Objective: Current medications for alcohol use disorder do not target brain noradrenergic pathways. Theoretical and preclinical evidence suggests that noradrenergic circuits may be involved in alcohol reinforcement and relapse. After...
6.
Tulloch J, Leong L, Thomson Z, Chen S, Lee E, Keene C, et al.
Brain Res
. 2018 Aug;
1698:179-186.
PMID: 30081037
The apolipoprotein E gene (APOE) is the strongest genetic risk factor for developing Alzheimer's disease (AD). Our recent identification of altered APOE DNA methylation in AD postmortem brain (PMB) prompted...
7.
Hendrickson R, Raskind M, Millard S, Sikkema C, Terry G, Pagulayan K, et al.
Neurobiol Stress
. 2018 Jun;
8:103-111.
PMID: 29888305
Background: Increases in the quantity or impact of noradrenergic signaling have been implicated in the pathophysiology of posttraumatic stress disorder (PTSD). This increased signaling may result from increased norepinephrine (NE)...
8.
Tulloch J, Leong L, Chen S, Keene C, Millard S, Shutes-David A, et al.
Alzheimers Dement
. 2018 Mar;
14(7):889-894.
PMID: 29544979
Introduction: Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person's risk of developing both Alzheimer's disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind...
9.
Pagulayan K, Rau H, Madathil R, Werhane M, Millard S, Petrie E, et al.
J Int Neuropsychol Soc
. 2017 Dec;
24(4):324-334.
PMID: 29284552
Objectives: To evaluate prospective and retrospective memory abilities in Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans with and without a self-reported history of...
10.
Li G, Mayer C, Morelli D, Millard S, Raskind W, Petrie E, et al.
Neurology
. 2017 Aug;
89(12):1251-1255.
PMID: 28821686
Objective: To examine potential disease-modifying effects of statin drugs, we conducted a 12-month randomized, placebo-controlled clinical trial of simvastatin in cognitively normal adults using change in CSF Alzheimer disease biomarkers...